Argenx Se (ARGX) Work In Process (2020 - 2023)

Argenx Se (ARGX) posted Work In Process of $47.1 million for Q4 2023, down 27.6% on a QoQ basis from $65.0 million in Q4 2022, and down 27.6% year-over-year from $65.0 million in Q4 2022.

Argenx Se (ARGX) Work In Process (2020 - 2023) Analysis & Trends

Argenx Se's Work In Process history runs 4 years deep, the most recent figure standing at $47.1 million for Q4 2023.

  • Quarterly Work In Process fell 27.6% year-over-year to $47.1 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $47.1 million (down 27.6% YoY) and the FY2023 annual result came in at $47.1 million, down 27.6% from the prior year.
  • Work In Process was $47.1 million for Q4 2023 at Argenx Se, down from $65.0 million in the prior quarter.
  • Across five years, Work In Process topped out at $65.0 million in Q4 2022 and bottomed at $6.4 million in Q4 2020.
  • A 4-year average of $39.0 million and a median of $42.4 million in 2021 frame the typical range for Work In Process.
  • Annual changes were most pronounced in 2021 — Work In Process jumped 489.12% — and 2023, when it fell 27.6%.
  • Argenx Se's Work In Process stood at $6.4 million in 2020, then soared by 489.12% to $37.7 million in 2021, then soared by 72.43% to $65.0 million in 2022, then decreased by 27.6% to $47.1 million in 2023.
  • Business Quant data shows ARGX's Work In Process at $47.1 million in Q4 2023, $65.0 million in Q4 2022, and $37.7 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 47.07 Mn
Dec 31, 2022 65.02 Mn
Dec 31, 2021 37.71 Mn
Dec 31, 2020 6.40 Mn